Logo for Revenio Group

Revenio Investor Relations Material

Latest events

Logo for Revenio Group

Q1 2024

Revenio
Logo for Revenio

Q1 2024

25 Apr, 2024
Logo for Revenio

Q4 2023

15 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Revenio Group

Access all reports
Segment Data
Access more data
Net sales by
Geography
North America
Other Europe
Finland
Other
Expenses by
Financials
Revenio Group Oyj designs, manufactures, and sells medical instruments for the early detection of glaucoma, diabetic retinopathy, and macular degeneration. The company's vision is to create a world without blindness. It offers ophthalmology and optometry products like the Topcon Refractometer, the Diagnolyzer FT, the Diabetoscan DR/A1C+, and the XDM-400 Cell Health Analyzer; cell health analysis systems for measuring cellular health of skin cells, bone marrow cells and dental pulp cells; as well as other medical devices that measure the mechanical stress of tissues by stethoscopy (examination of tissues via a stethoscope) and laser Doppler flowmetry (measures blood flow in tissue), and enables quantitative analysis of renal function. The company is based in Vantaa, Finland.